, under the appropriate conditions, can undergo apoptosis. Apoptosis (programmed cell death) is Endometriosis, a debilitating disease associated with infertilcritical to a number of physiological and pathological processes ity, is characterized by the prolonged presence of ectopic (Williams et al., 1994; Williams, 1994) . It is distinct from cell endometrial tissue and the involvement of activated peritondeath induced by toxic effects (necrosis) and is characterized eal fluid macrophages. Apoptosis, which occurs in both endoby specific morphological features (Kerr et al., 1993) . In metrium and peritoneal fluid macrophages, is controlled in the endometrium it is commonly observed in the glandular part by members of the Bcl-2/Bax family of proteins. Here, epithelium, and increases in frequency as the secretory phase through immunohistochemical staining, we investigated the of the menstrual cycle progresses, peaking during menstruation Bcl-2/Bax status in endometrium and peritoneal fluid macro- (Tabibzadeh et al., 1994) . Although the precise regulation of phages in endometriosis. Bcl-2/Bax immunoreactivity was apoptosis in this tissue is unclear, work in rabbit and human found predominately in the glandular epithelial cells, mainly endometrium suggests that progesterone (Nawaz et al., 1987 ; during the proliferative phase of the menstrual cycle for Bcl- Rotello et al., 1989) and tumour necrosis factor (TNF)-α 2 but throughout the entire menstrual cycle for Bax. Ectopic (Tabibzadeh et al., 1995) are involved. endometrium contained a population of Bcl-2 positive, Bax Activation of macrophages is critical for their host defence negative tissue macrophages. Fluorescence-activated cell response (Adams and Hamilton, 1992) . However, if not consorting of isolated peritoneal fluid macrophages showed that trolled these cells may damage the host by the unrestrained women with endometriosis had a significantly higher proporproduction of free radicals, lytic enzymes and cytokines tion of Bcl-2 positive macrophages than the non-endometri- (Nathan et al., 1980) . Apoptosis is one mechanism which otic group. The proportion of Bax positive peritoneal fluid controls the activity of these cells (Munn et al., 1995) . macrophages was significantly elevated in women without Therefore, any alterations in the response of the ectopic endometriosis. The increased proportion of Bcl-2 positive endometriotic tissue, and peritoneal fluid macrophages to macrophages found in women with endometriosis may preapoptotic stimuli may have important implications for the dispose these cells to resist apoptosis. The continued survival survival of the ectopic tissue and the subsequent development of these active cells could have important consequences for of endometriosis. the survival and proliferation of the ectopic endometrial Apoptosis is controlled by the expression of a number of tissue.
regulatory genes, including c-myc, p53 and apo-1/fas (White, Key words: apoptosis/Bax/Bcl-2/endometriosis/peritoneal fluid 1993; Osborne and Schwartz, 1994; Nagata and Golstein, macrophages 1995) . However, one of the most important advances in our understanding of apoptotic cell death has come from studies of the oncogenic Bcl-2 family. Bcl-2 promotes cell survival Introduction by blocking apoptosis induced by a range of stimuli including growth factor withdrawal (Nunez and Clarke, 1994) . ImmunoEndometriosis, the presence of endometrium outside of the uterine cavity, is a common disease, causing abdominal pain, reactive Bcl-2 in endometrium is mainly localized in the glandular epithelium with maximal expression during the dysmenorrhoea, dyspareunia and infertility in~10% of the female population (Strathy et al., 1982) . Its aetiology is unclear proliferative phase of the cycle, which gradually disappears or is markedly reduced during the secretory phase (Gompel et al., but it is thought to be due to the implantation and maintenance of disseminated uterine endometrium, predominately on the 1994; Otsuki et al., 1994; Koh et al., 1995) . The disappearance of Bcl-2 coincides with the observed increase in the incidence ovary and pelvic peritoneum (Thomas and Prentice, 1992) . The peritoneal cavity, the commonest site of endometriosis of apoptosis during this phase of the cycle. It is now clear that the anti-apoptotic properties of Bcl-2 depend acutely on its (Jenkins et al., 1986) , contains fluid whose major cellular
Immunohistochemical staining
interaction with a number of potent antagonistic proteins (Bosie et al., 1993; Keifer et al., 1995; Yang et al., 1995) . In Formalin-fixed paraffin-embedded sections of endometrium from women with and without endometriosis were de-paraffinized in xylene particular, recent studies have shown that a related protein, and hydrated gradually through graded alcohols. Antigenic unmasking Bax, antagonizes the survival-promoting activity of Bcl-2 was achieved by pressure cooking the slides for l min in 0.01 M (Oltvai et al., 1993) . Bcl-2 needs to form heterodimers with sodium citrate. The slides were then incubated for 20 min in 10%
Bax in order to function, and it is the ratio of Bcl-2 to goat serum to block non-specific binding, before incubation for l h Bax which predetermines the cells' susceptibility to a given with either a 50-fold diluted anti-human Bcl-2 mouse monoclonal apoptotic stimulus (Oltvai and Korsmeyer, 1994) . in endometrium and isolated peritoneal fluid macrophages from women with and without endometriosis.
Double immunofluorescence staining
Fluorescence double-staining for either Bcl-2 positive tissue macrophages or Bax positive tissue macrophages was carried out on all
Materials and methods
endometrial tissue sections. Sections were pre-treated as above, before incubating for l h in the dark with either a 10-fold diluted fluorescein Patient details isothiocyanate (FITC)-conjugated anti-human Bcl-2 antibody (Dako) Women aged 24-44 years who were undergoing either diagnostic or a 500-fold diluted anti-human Bax rabbit polyclonal antibody. Bax laparoscopy for pain, infertility or tubal ligation were included in this slides were then incubated for l h in the dark, with a 200-fold diluted study. Endometriosis was diagnosed laparoscopically and confirmed FITC-conjugated anti-rabbit F(ab) 2 antibody fragment (Dako). Tissue histologically. Endometrium from women without endometriosis macrophages were identified using phycoerthyrin (PE)-conjugated (n ϭ 10) (normal endometrium) and eutopic endometrium (n ϭ 10) macrophage marker Leu M3 (CD14). Slides were washed and mounted (located within the uterine cavity) and paired ectopic endometrium in aqueous mounting medium and viewed immediately. An irrelevant (n ϭ 10) (biopsied from the peritoneum) from women with endomeisotype-matched mouse monoclonal antibody or peptide pre-absorptriosis, throughout the menstrual cycle, were used in this study. Each tion of rabbit polyclonal antibody were used as negative controls group contained five proliferative and five secretory phase samples.
respectively. Peritoneal fluid samples were collected from women with (n ϭ 24) and without endometriosis (n ϭ 24), throughout the menstrual cycle.
Flow cytometry Each group contained 12 proliferative phase and 12 secretory phase Peritoneal fluid macrophages were isolated, as previously described, samples. The extent of endometriosis was determined according to and washed with PBS containing 2% fetal calf serum and adjusted the revised American Fertility Society scoring system (American to a concentration of 1-2ϫ10 6 cells/ml. The cells were first incubated Fertility Society, 1985) . All patients included in this study had with heat inactivated swine serum (56°C) for 20 min at room minimal to moderate endometriosis (scoring 1-12). This study was temperature to block non-specific Fc receptor binding. Following this approved by the ethics committee of Addenbrookes NHS and written the cells were fixed by incubating with 0.25% paraformaldehyde for informed consent was obtained from each patient.
15-20 min in the dark at room temperature and permeabilized by incubating with 70% methanol for 60 min at 4°C. Cells were labelled Isolation of peritoneal fluid macrophages for Bcl-2 with a 10-fold diluted FITC-conjugated anti-human Bcl-2 Peritoneal fluid was aspirated from the posterior cul-de-sac using a antibody and for Bax, the cells were labelled with a 500-fold diluted Veress needle. Macrophages were isolated by centrifugation through anti-human Bax rabbit polyclonal followed by FITC-conjugated antiFicoll-Hypaque 1077 (Sigma, Poole, UK) at room temperature for rabbit F(ab) 2 antibody fragment. Macrophages were identified using 10 min at 400 g. Cells were washed in phosphate-buffered saline the PE-conjugated macrophage marker Leu M3 (CD14). The negative (PBS) and counted before being resuspended at a concentration of control for Bcl-2 comprised cells treated with an isotype-matched 1ϫ10 6 cells/ml in PBS/1% bovine serum albumin (BSA). This method control antibody. Controls for Bax consisted of the same polyclonal of isolation results in an enriched population of peritoneal fluid antibodies which had previously being pre-absorbed with control macrophages (Ͼ95%) which are not activated during the isolation peptide. In addition, tubes containing only swine anti-rabbit-FITC procedure (Halme et al., 1983 (Halme et al., , 1987 . F(ab) 2 -labelled and an irrelevant directly PE-labelled monoclonal antibody were also used. The cells were then washed twice, resusCollection of ectopic and eutopic endometrium pended in PBS and analysed using fluorescence-activated cell (FAC) sorting (Becton Dickinson) flow cytometer with Lysis II software If the diagnosis of endometriosis was made, a second portal was (Becton Dickinson). inserted in the right iliac fossa through the rectus abdominus muscle lateral to the inferior epigastric vessels. A punch biopsy was obtained Statistical analysis under direct vision on the video monitor. Eutopic tissue was obtained from the uterine cavity after gentle dilatation of the cervix to Heger Statistical analysis was determined on original data from FAC-sorted peritoneal fluid macrophage samples. The data was not normally 8. Strips of endometrium were obtained by sharp curettage. 2A,B). Significant stromal staining for Bcl-2 was absent in all samples ( Figures 1A,B and 2A,B) with the exception of lymphoid cells which were immunopositive in all endometrium Results samples stained, and throughout both phases of the menstrual Immunohistochemical staining for Bcl-2 cycle ( Figures 1A,B and 2A,B) . In paired eutopic endometrium Eutopic and normal endometrium from women with or without and normal endometrium most of the Bcl-2 positive lymphoid endometriosis was characterized in the proliferative phase by cells were seen during the secretory phase. Endothelial cells in strong immunoreactivity for Bcl-2 in the glandular epithelium all samples were negative for Bcl-2, as was the surrounding which continued through into the early secretory phase of the vascular smooth muscle. cycle and was lost in samples obtained from the mid-late secretBcl-2 positive tissue macrophages in ectopic endometrium ory phase ( Figure 1A,B) . Ectopic endometrium from women with endometriosis followed a similar pattern of staining to that Staining for Bcl-2 in the ectopic endometrium from women with endometriosis revealed a population of Bcl-2 positive found in eutopic tissue, with strong glandular immunoreactivity cells which were morphologically uncharacteristic of lymphoperitoneal fluid macrophages was significantly higher (P Ͻ0.05) in women with endometriosis (median 45%, range cytes. Following double fluorescence staining for both the macrophage marker Leu M3 (CD14) and the Bcl-2 protein it 5-95%) compared with that seen in women without (median 14.5%, range 7-27%) (Figure 3) . Women with endometriosis was demonstrated that these cells were Bcl-2 immunopositive macrophages ( Figure 2E,F) . Three out of the five proliferative showed a cycle-dependent variation in the number of Bcl-2 positive macrophages, with significantly (P Ͻ0.01) more Bcl-2 and four out of the five secretory phase ectopic endometrium samples contained Bcl-2 positive macrophages, although the positive macrophages present in the proliferative phase (median 85.5%, range 40-95%) in comparison with the secretory phase number of cells varied. Immunohistochemical staining for Bcl-2 in paired eutopic endometrium or endometrium from of the cycle (median 17%, range 5-50%) (Figure 3 ). However, no cycle differences were seen in samples from women without normal subjects failed to identify any significant population of Bcl-2 positive macrophages.
endometriosis. The number of Bcl-2 positive peritoneal fluid macrophages found in the proliferative phase of the cycle Bcl-2 positive peritoneal fluid macrophages in women with endometriosis was also significantly greater (P Ͻ0.01) than that in both proliferative (median 14.5%, range FAC sorting of peritoneal fluid macrophages for Bcl-2 protein demonstrated Bcl-2 positive macrophages in women with and 7-23%) and secretory (median 15%, range 7-25%) phases of the cycle from women without endometriosis (Figure 3) . without endometriosis. The overall proportion of Bcl-2 positive macrophages in women without endometriosis (median 24%, range 12-42%) compared with those with endometriosis (median 12.5%, range 2-27%). No cycle-dependent variation in their number was seen (Figure 3) .
Discussion
In this report we have compared for the first time the in-vivo distribution of both Bcl-2 and Bax using immunohistochemical staining in endometrium from normal subjects and eutopic/ ectopic endometrium from women with pelvic endometriosis. We demonstrated a similar cyclical pattern of Bcl-2 immunoreactivity in the eutopic/ectopic epithelium to that previously described in normal endometrium (Gompel et al., 1994; Otsuki et al., 1994; Koh et al., 1995; Tabibzadeh et al., 1995) and adenomyotic tissue (Harada et al., 1996) . However, these authors also reported a lack of Bcl-2 staining in ovarian endometriosis. This suggests pelvic endometriosis and adenomyosis may have similar Bcl-2 regulating characteristics to eutopic endometrial tissue, but different to those that exist in ovarian endometriosis. It may also indicate a difference in the pathogenesis between adenomyosis/pelvic endometriosis and ovarian endometriosis.
The persistent immunopositivity for the Bcl-2 antagonist protein, Bax, in the glandular epithelial cells of all endometrium throughout the menstrual cycle, implies that its expression is not hormonally regulated. Recent work by Teixerira et al. (1995) supports this, showing that Bcl-2 but not Bax expression is regulated by oestradiol in MCF-7 human breast cancer cell will have a significant effect on the cells' ability to survive an were isolated from women with (n ϭ 24) and without (n ϭ 24) endometriosis, throughout the menstrual cycle. (a) number of Bcl-2 apoptotic stimulus (Oltvai et al., 1993) 1994). However, it must be remembered that there are a number of other apoptosis/anti-apoptosis-inducing pathways Immunohistochemical staining for Bax which may also influence the susceptibility of the cells to undergo apoptosis (Vinatier et al., 1996) . Immunohistochemical staining for Bax, during the proliferative phase of the cycle, showed an identical pattern to that of The co-expression of Bcl-2 and Bax in the glandular epithelium during the proliferative phase of the cycle may Bcl-2 ( Figures 1C and 2C) , with staining localized almost exclusively in the glandular epithelial cells. However, contrary explain the absence of apoptosis seen during this period. The persistence of Bax staining in the glandular epithelium, of to the lack of Bcl-2 staining in secretory phase samples the pattern of staining for Bax was maintained throughout the both normal and eutopic/ectopic endometrium, in the absence of Bcl-2 in the secretory phase may predispose these cells to entire secretory phase of the cycle (Figures 1D and 2D) . Stromal cells or lymphocytes did not stain for Bax at any undergo apoptosis during this period. In addition, an increase in apoptosis in the glandular epithelium during the secretory stage of the menstrual cycle, in either women with or without endometriosis. Endothelial cells were immunopositive for Bax phase of the cycle is well documented in normal endometrium (Tabibzadeh et al., 1994) along with increases in apoptosisthroughout the cycle and in all stained endometrium. No Bax positive tissue macrophages were seen in any samples.
inducing cytokines such as TNF-α (Tabibzadeh et al., 1995) . A similar lack of Bcl-2 staining was evident in ovarian Bax positive peritoneal fluid macrophages endometriosis which also coincided with the appearance of apoptosis (Harada et al., 1996) . However, apoptosis was not FAC sorting of peritoneal macrophages for Bax protein demonstrated a significantly higher number (P Ͻ0.01) of Bax positive measured in our samples so the association between the lack of Bcl-2, maintenance of Bax and the subsequent appearance changes in the steroid environment. We have shown previously of apoptosis was not confirmed.
that peritoneal fluid macrophages contain mRNA encoding Immunohistochemical staining revealed a population of Bcloestrogen and progesterone receptors, are also immunoreactive 2-positive, Bax negative tissue macrophages present only in for these receptors and can respond to direct stimulation by ectopic tissue during both phases of the cycle. The expression steroids (McLaren et al., 1996) . Thus steroids may directly of Bcl-2 and absence of Bax may confer on these cells a regulate apoptosis in peritoneal fluid macrophages. decreased susceptibility to apoptosis, given the known properIn summary, eutopic and ectopic endometrium are immunoties of Bcl-2 and Bax, and may result in an extended life positive for Bcl-2 and Bax in patients with endometriosis. The expectancy. Macrophages are highly active cells and in addition cyclical pattern of immunoreactivity for Bcl-2 is similar to to their phagocytic and immunomodulatory properties can that seen in endometrium from normal subjects and suggests secrete an extensive range of growth and angiogenic factors regulation by ovarian steroids. Bax demonstrated no cyclical (Sunderkotter et al., 1991; Adams and Hamilton, 1992) .
pattern of staining. Therefore the presence of a population of potentially highly
The presence of Bcl-2 positive Bax negative macrophages active macrophages, which are selected for survival, within in endometriotic tissue gives rise to the possibility of a the ectopic tissue may have important implications in pathopopulation of potentially highly active secretory cells, with physiology of endometriosis. This takes on added importance reduced susceptibility to apoptosis, exerting their secretory since we have recently demonstrated, in ectopic endometrium, effects within the ectopic tissue. The elevated population the presence of tissue macrophages which are immunopositive of Bcl-2 positive peritoneal macrophages in women with for the potent angiogenic growth factor, vascular endothelial endometriosis may predispose these cells to survive activation growth factor (VEGF) (McLaren et al., 1996) . and resist apoptosis. The continued survival of these activated The majority of endometriotic tissue is bathed by peritoneal cells would have important consequences for the survival and fluid whose main cellular constituent is peritoneal fluid macroproliferation of endometriosis. phages (Eischen et al., 1994) . These cells have been shown to secrete an extensive array of soluble factors including TNF-α (Halme, 1989), interleukin (IL)-1β (Polan et al., 1989) , IL-1 References (Simoni et al., 1994) , IL-6 (Rier et al., 1994) , interferon
